Holen Sie sich die Stockscreener-App
2.85
5.63%
-0.17
Handel nachbörslich:
2.94
0.09
+3.16%
Finanzdaten der Sonnet Biotherapeutics Holdings Inc-Aktie (SONN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
100.00%
-
|
0.0186 | 0.0373 | 0.0369 | 0.0364 |
Operating Expenses
|
198.16%
3.8686
|
1.2975 | 3.6374 | 3.9522 | 5.7012 |
| Benefits Costs and Expenses |
0.8217
|
- | - | - | - |
| Costs And Expenses |
198.16%
3.8686
|
1.2975 | 3.6374 | 3.9522 | 5.7012 |
| Operating Income/Loss |
202.50%
-3.8686
|
-1.2789 | -3.6001 | -3.9153 | -5.6648 |
| Income/Loss From Continuing Operations Before Tax |
131.27%
0.3654
|
-1.1685 | 0.0373 | 0.0369 | -5.6671 |
| Income/Loss From Continuing Operations After Tax |
131.27%
0.3654
|
-1.1685 | -3.6767 | -3.9467 | -5.6671 |
|
Net Income/Loss
|
131.27%
0.3654
|
-1.1685 | -3.6767 | -3.9467 | -5.6671 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
21.59%
4.6177
|
3.7978 | -16.53 | 29.38 | 16.51 |
| Diluted Average Shares |
28.65%
4.8858
|
3.7978 | -16.53 | 29.38 | - |
| Basic Earnings Per Share |
125.81%
0.08
|
-0.31 | -17.28 | -0.13 | -0.34 |
| Diluted Earnings Per Share |
122.58%
0.07
|
-0.31 | -17.28 | -0.13 | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):